Home > News > Nanogen shares soar on patent
December 3rd, 2003
Abstract:
Shares of Nanogen Inc. jumped more than 50 percent Wednesday after the company said it received a U.S. patent related to the fledgling field of nanotechnology and nanomanufacturing. San Diego-based Nanogen, which develops molecular diagnostic products for genetic testing, said the new patent could lead to nanoscale electronic and photonic devices for data storage or medical diagnostics. Nanogen Issued Key Nanotechnology Patent
Source:
Forbes
Bookmark:
| Related News Press |
Announcements
Arrowhead Pharmaceuticals Presents Late-Breaking Clinical Data on ARO-AAT at Liver Meeting® 2018 November 9th, 2018
Arrowhead Pharmaceuticals Presents Late-Breaking Preliminary Clinical Data on ARO-HBV at Liver Meeting® 2018 November 9th, 2018
IEDM - CEA-Leti Will Present 11 Papers and Host Workshop on Disruptive Technologies for Data Management November 7th, 2018
Patents/IP/Tech Transfer/Licensing
Arrowhead Pharmaceuticals Announces Closing of Agreements with Janssen October 31st, 2018
180 Degree Capital Corp. Announces New Portfolio Holdings – Airgain, Inc., EMCORE Corporation, Lantronix, Inc. and PDL BioPharma, Inc. October 12th, 2018
Arrowhead Enters $3.7 Billion License and Collaboration Agreements with Janssen October 4th, 2018
Silvaco, Purdue team up to bring scalable atomistic TCAD solutions for next generation semiconductor devices and materials August 24th, 2018
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||